Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $456.25 million. The enterprise value is $201.60 million.

Market Cap	456.25M
Enterprise Value	201.60M

Important Dates

The last earnings date was Thursday, March 5, 2026, after market close.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

CTNM has 37.34 million shares outstanding. The number of shares has increased by 43.14% in one year.

Current Share Class	32.67M
Shares Outstanding	37.34M
Shares Change (YoY)	+43.14%
Shares Change (QoQ)	+9.77%
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	60.71%
Float	25.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.75
P/TBV Ratio	1.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.50, with a Debt / Equity ratio of 0.03.

Current Ratio	27.50
Quick Ratio	26.98
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.13% and return on invested capital (ROIC) is -1,375.07%.

Return on Equity (ROE)	-26.13%
Return on Assets (ROA)	-17.38%
Return on Invested Capital (ROIC)	-1,375.07%
Return on Capital Employed (ROCE)	-25.50%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +73.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+73.09%
50-Day Moving Average	13.64
200-Day Moving Average	10.19
Relative Strength Index (RSI)	37.61
Average Volume (20 Days)	277,567

Short Selling Information

The latest short interest is 2.55 million, so 6.83% of the outstanding shares have been sold short.

Short Interest	2.55M
Short Previous Month	2.58M
Short % of Shares Out	6.83%
Short % of Float	10.05%
Short Ratio (days to cover)	11.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.06M
Pretax Income	-59.98M
Net Income	-59.98M
EBITDA	-67.74M
EBIT	-68.06M
Earnings Per Share (EPS)	-$2.17

Balance Sheet

The company has $262.90 million in cash and $8.25 million in debt, with a net cash position of $254.65 million or $6.82 per share.

Cash & Cash Equivalents	262.90M
Total Debt	8.25M
Net Cash	254.65M
Net Cash Per Share	$6.82
Equity (Book Value)	260.99M
Book Value Per Share	6.99
Working Capital	258.17M

Cash Flow

In the last 12 months, operating cash flow was -$55.31 million and capital expenditures -$231,000, giving a free cash flow of -$55.54 million.

Operating Cash Flow	-55.31M
Capital Expenditures	-231,000
Free Cash Flow	-55.54M
FCF Per Share	-$1.49

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.14%
Shareholder Yield	-43.14%
Earnings Yield	-13.15%
FCF Yield	-12.17%

Analyst Forecast

The average price target for CTNM is $19.80, which is 62.03% higher than the current price. The consensus rating is "Buy".

Price Target	$19.80
Price Target Difference	62.03%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2